GILDER GAGNON HOWE & CO LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 234 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$135,000
-96.0%
6,022
-94.7%
0.00%
-95.7%
Q4 2017$3,391,000
-26.9%
112,626
-8.6%
0.05%
-29.2%
Q3 2017$4,640,000
+1387.2%
123,171
+1000.8%
0.06%
+1200.0%
Q2 2017$312,000
+1.3%
11,189
+25.1%
0.01%0.0%
Q1 2017$308,000
+1000.0%
8,946
+821.3%
0.01%
+400.0%
Q4 2016$28,000
-84.4%
971
-82.8%
0.00%
-66.7%
Q3 2016$179,000
+18.5%
5,629
+21.3%
0.00%0.0%
Q2 2016$151,000
+15.3%
4,639
-0.7%
0.00%0.0%
Q1 2016$131,000
-97.4%
4,671
-96.6%
0.00%
-96.2%
Q4 2015$4,957,000
-51.3%
139,034
-54.8%
0.08%
-50.3%
Q3 2015$10,180,000
-21.9%
307,831
-1.1%
0.16%
-5.8%
Q2 2015$13,032,000
+26.0%
311,184
-1.9%
0.17%
+18.8%
Q1 2015$10,339,000
-80.6%
317,235
-81.1%
0.14%
-81.8%
Q4 2014$53,167,000
+27.1%
1,674,562
-0.8%
0.79%
+30.1%
Q3 2014$41,817,000
+8.1%
1,688,889
-1.4%
0.61%
+18.5%
Q2 2014$38,675,000
-24.6%
1,712,053
-18.8%
0.51%
-26.6%
Q1 2014$51,321,000
-0.3%
2,109,364
+2.4%
0.70%
-4.8%
Q4 2013$51,468,000
+11.6%
2,059,529
+22.7%
0.73%
+1.9%
Q3 2013$46,127,0001,679,1760.72%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders